4 jobs
Bluetree Cambridge £65,000 – £80,000 pa
Lead regulatory strategy for a cardiology device company expanding into the US, UK, EU and Middle East, owning FDA, CE and UKCA submissions from Class I to Class II/III. Drive an audit-ready QMS (ISO 13485, 21 CFR Part 820, ISO 14971) and advise senior leadership on regulation, quality and clinical governance, working directly with the FDA, MHRA and notified bodies.
Johnson & Johnson MedTech Maidenhead
Lead a two-year postdoctoral research program on making agentic AI safe for pharmaceutical R&D, covering provable controls, adversarial assurance, and safety-native architecture. You will design reproducible experiments, prototype layered safeguards, publish results, and work with platform engineers to move validated methods into a GenAI platform.
Johnson & Johnson MedTech Limerick, Ireland
Lead a two-year postdoctoral research program on making agentic AI safe for pharmaceutical R&D, covering provable controls, adversarial assurance and safety-native architecture. Hands-on work prototyping and validating methods on real GenAI platform workflows, publishing results and handing validated approaches to engineering partners.
Johnson & Johnson MedTech Beerse, Belgium
Lead a two-year postdoctoral research program on making agentic AI safe for regulated pharmaceutical R&D, covering provable controls, adversarial assurance, and safety-native architecture. You will design reproducible experiments, prototype layered architectures, and work with platform engineers to move validated methods into a GenAI platform. The role is hands-on research with real systems as the testbed, not frontier model pre-training or production engineering.
Johnson & Johnson MedTech Leiden, Netherlands
Lead a two-year postdoctoral research program on making agentic AI safe for pharmaceutical R&D, covering provable controls, continuous adversarial red-teaming, and safety-native architecture. Hands-on work prototyping and validating methods on real GenAI platform workflows, publishing results, and transitioning validated approaches into production with engineering partners.
